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Hepatitis C Screening in
the Baby Boomer
Population
PEDRAM ZARGARI

FAMILY MEDICINE ROTATION JULY/AUGUST 2018 SWANTON/ST. ALBANS
MICHAEL CORRIGAN M.D./ MAX BAYARD M.D.

Problem Identification and Description
of Need


Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United
States, with approximately 2.7-3.9 million people living with chronic infections. (1)



Approximately 75%–85% of people who become infected with hepatitis C virus will
develop a chronic infection. (2) From those infected, up to 75% are unaware of it due to
the asymptomatic nature of the disease. (3)



Those born between the years 1945-1965 are at a five-fold increased risk of HCV infection.
Hepatitis C is a leading cause of cirrhosis, hepatocellular carcinoma, and liver
transplantations; people born during 1945-1965 account for 73% of all hepatitis Cassociated mortality. (4)



According to surveillance surveys, an estimated 12,000 people are infected with Hepatitis
C in Vermont. There are now over 200,000 Vermonters born from 1945 to 1965 who need
to be screened solely due to the birth cohort.



With the advancement of modern medicine, new therapies have emerged that can cure
chronic HCV infections in a short duration of time with few associated side effects, thus
increasing the importance of screening for the disease and intervening to halt its progress.

Public health cost



In 2013 the total cost of Hepatitis C burden in the U.S. was estimated at
$6.5 ($4.3-$8.4) billion and it is expected to peak in 2024 at $9.1 ($6.4-$13.3)
billion (5)



The lifetime cost of an individual infected with HCV in 2011 was estimated
at $64,490 (5)



One-time testing of the baby boomer cohort is estimated to identify
800,000 infections and, with linkage to care and treatment, avert more
than 120,000 HCV-related deaths. This preventative strategy is estimated
to save $1.5-$7.1 billion in liver disease-related costs. (4)

Community perspective and support





Dr. Max Bayard


“Undoubtedly a lot of people are not seeing, or have access to, doctors to get
screened for Hepatitis C infection”



“Doctors also need to be educated to remember and address Hepatitis C as part
of the routine screening in the baby boomer population”

Dr. Michael Corrigan


“A few years ago, we were amazed at how many of our patients with a history of
high risk behavior tested positive for Hepatitis C- Antibodies and subsequently
Hepatitis C viral RNA. We then began screening in the baby boomer age group
with and without a history of high risk behavior. We continued to identify many
asymptomatic infected people and referred them onto treatment and a cure.”

Intervention and Methodology



Project Objective: To raise awareness and educate patients within the
baby boomer population to get screened for Hepatitis C.



Methodology: A literature review was conducted regarding the utility and
efficacy of Hepatitis C screening and an 8.5x11” poster was created to be
posted in both Dr. Corrigan and Dr. Bayard’s office waiting rooms.


The poster was made to educate and inform patients about the risks and
previous exposures that could potentially lead to an infection with HCV.



The poster aims to start a conversation about preventative medicine between
the patient and the provider and ultimately it aims to increase the amount of
patients within the baby boomer cohort to get tested for HCV.

Results: Poster

Evaluation of effectiveness and
limitations


The poster was reviewed and approved by Dr. Bayard and other
healthcare providers in the St. Albans NOTCH clinic. The Poster was also
reviewed by Dr. Corrigan and received a positive response and reaction.



The poster was completed and displayed towards the end of the rotation
thus my ability to gauge its effectiveness is very limited due to time.



Hepatitis C infection is also a complex disorder with multiple variables,
making it difficult to effectively portray an educational message to the
laymen on such a poster.



The actual size of the poster (8.5 x 11”) is also small, which limits the amount
of attention it could attract from patients, especially the visually impaired.

Recommendations for future
interventions/projects


Follow up in six months to quantify the number of Hepatitis C screening tests
that have been ordered after the poster was displayed in comparison to six
months prior to the poster being displayed.



Another great way of raising awareness for screening would be to approach it
from the providers angle and have them bring up the topic to every patient
that falls withinin this cohort. Due to the small office settings this can be a
protocol change for all providers practicing in that clinic.



Additionally, asking about previous Hep C testing in the new patient
questionnaires and intake forms would give the providers more information
about their patient population.



Another intervention can be in the form of an automatic reminder from the
EMR which prompts the provider that this patient has never been tested and to
inquire about possible screening.
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